BNT162b2 Vaccine Effectiveness Against the SARS-CoV-2 Omicron Variant in Children Aged 5 to 11 Years
Author:
Affiliation:
1. Korea Disease Control and Prevention Agency, Cheongju, Korea
2. Korea University Anam Hospital, Seoul, Korea
Abstract
Publisher
American Medical Association (AMA)
Subject
Pediatrics, Perinatology and Child Health
Link
https://jamanetwork.com/journals/jamapediatrics/articlepdf/2800322/jamapediatrics_jang_2023_ld_220050_1677804731.23639.pdf
Reference5 articles.
1. Coronavirus disease 2019 disease severity in children infected with the omicron variant.;Butt;Clin Infect Dis,2022
2. BNT162b2 vaccine effectiveness against omicron in children 5 to 11 years of age.;Cohen-Stavi;N Engl J Med,2022
3. Effectiveness of 2-dose BNT162b2 (Pfizer BioNTech) mRNA vaccine in preventing SARS-CoV-2 infection among children aged 5-11 years and adolescents aged 12-15 years: PROTECT cohort, July 2021-February 2022.;Fowlkes;MMWR Morb Mortal Wkly Rep,2022
4. Effectiveness of BNT162b2 vaccine against SARS-CoV-2 infection and severe COVID-19 in children aged 5-11 years in Italy: a retrospective analysis of January-April, 2022.;Sacco;Lancet,2022
5. Effectiveness of BNT162b2 vaccine against omicron in children 5 to 11 years of age.;Tan;N Engl J Med,2022
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Clinical characteristics of SARS-CoV-2-associated encephalopathy in children: Nationwide epidemiological study;Journal of the Neurological Sciences;2024-02
2. More common RNAemia in the early stage of severe SARS-CoV-2 BF.7.14 infections in pediatric patients;Biosafety and Health;2023-12
3. Clinical characteristics of abruptly increased paediatric patients with Omicron BF.7 or BA.5.2 in Beijing;Virology Journal;2023-09-08
4. Safety and effectiveness of vaccines against COVID-19 in children aged 5–11 years: a systematic review and meta-analysis;The Lancet Child & Adolescent Health;2023-06
5. Error in Author Affiliations;JAMA Pediatrics;2023-03-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3